Vitruvian Shield
About · Scientific Advisory Board

Scientific Advisory Board & Investigator Network

The clinicians, methodologists, and translational researchers who shape Vitruvian Shield and run the studies on it.

Role of the Board

The Scientific Advisory Board provides scientific oversight of the platform, reviews protocols submitted by partner institutions, contributes to publications under the ICMJE authorship criteria, and validates the platform against the requirements of decentralized and hybrid clinical research. The Board is composed of academic clinicians, methodologists, and principal investigators from the institutions running active studies on Vitruvian Shield.

Current members and investigators

Seats reserved for the IPN academic partners, the principal investigators of the active Portuguese studies, and two further advisor positions currently in confirmation.

IPN Academic Partner

Pending Confirmation

Instituto Pedro Nunes

Areas of expertise

Decentralized clinical trialsTranslational research

IPN Academic Partner

Pending Confirmation

Instituto Pedro Nunes

Areas of expertise

Clinical innovationHealthcare technology transfer

Principal Investigator — Oncology Pilot

Pending Confirmation

ULS São João

Areas of expertise

OncologyRemote patient monitoringDecentralized trials

Principal Investigator — PT-EPI-DCT-002

Pending Confirmation

Pending publication authorisation

Areas of expertise

EpilepsyNeurologyWearable biosensors

Advisor Seat — Pending Confirmation

Pending Confirmation

Advisor Seat — Pending Confirmation

Pending Confirmation

Cards marked Pending Confirmation will be populated with named investigators and endorsement statements once each institution clears the relevant photograph, biography, and quote for publication.

Discuss a study collaboration

If you are an academic investigator considering Vitruvian Shield for an upcoming study, the scientific team will work with you on protocol design, platform fit, and an institutional licence path before any commercial commitment.